P

Inventor

DANOS OLIVIER

US11 patents
⚠️ This page may combine multiple inventors who share the name “DANOS OLIVIER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PASTEUR INSTITUT

5 patents
US5906817AMay 25, 1999

Biocompatible implant for the expression and in vivo secretion of a therapeutic substance

PASTEUR INSTITUT171 citations96
US4551270ANov 5, 1985

DNA Fragments coding for polypeptides containing at least one antigenic determinant of the papillomavirus, particularly of the HPV 1a type and corresponding polypeptides

PASTEUR INSTITUT77 citations89
US5843638ADec 1, 1998

Nucleic acids and pepties of human immunodeficiency virus type-1 (HIV-1).

PASTEUR INSTITUT15 citations81
US6440657B1Aug 27, 2002

Nucleic acids and peptides of human immunodeficiency virus type (HIV-1)

PASTEUR INSTITUT9 citations74
US6326195B1Dec 4, 2001

Recombinant retroviral vector

PASTEUR INSTITUT10 citations71

WHITEHEAD INSTITUE FOR BIOMEDI

1 patent
US5449614ASep 12, 1995

Recombinant retroviruses with amphotropic and ecotropic host ranges

WHITEHEAD INSTITUE FOR BIOMEDI149 citations96

WHITEHEAD BIOMEDICAL INST

1 patent
US5955331ASep 21, 1999

Recombinant retroviruses with amphotropic and ecotropic host ranges

WHITEHEAD BIOMEDICAL INST47 citations95

AVENTIS PHARMA SA

1 patent
US6464998B1Oct 15, 2002

Composition for the in vivo production of therapeutic products

AVENTIS PHARMA SA28 citations90

CELL GENESYS INC

1 patent
US6936243B2Aug 30, 2005

Adeno-associated viral vector-mediated delivery of DNA to cells of the liver

CELL GENESYS INC36 citations89

DANOS OLIVIER

1 patent
US9290748B2Mar 22, 2016

Use of endonucleases for inserting transgenes into safe harbor loci

DANOS OLIVIER8 citations78

REGENXBIO INC

1 patent
US12247213B2Mar 11, 2025

Treatment of mucopolysaccharidosis IVA

REGENXBIO INC0 citations40